Common use of Immediate Termination by Sponsor Clause in Contracts

Immediate Termination by Sponsor. Sponsor may terminate this Agreement, terminate the conduct of the Trial under this Agreement, or terminate or suspend enrollment or randomization of Trial Participants immediately upon written notice to Provider and/or Investigator if (i) the Provider or Investigator fails to meet enrollment goals of the Trial as specified in the Protocol within the timeframe, if any, specified by Sponsor or fails to enroll any patient within the first 3 months after Trial initiation, (ii) Sponsor becomes aware of any efficacy or safety information that could significantly affect or alter continuation of the Trial, (iii) Sponsor terminates its conduct of the entire Trial in Sponsor’s sole discretion; or

Immediate Termination by Sponsor. Sponsor may terminate this Agreement, terminate the conduct of the Trial under this Agreement, or terminate or suspend enrollment or randomization of Trial Participants immediately upon written notice to Provider Institution and/or Investigator if (i) the Provider Institution or Investigator fails to meet enrollment goals of the Trial as specified in the Protocol within the timeframe, if any, specified by Sponsor or fails to enroll any patient within the first 3 months after Trial initiation, (ii) Sponsor becomes aware of any efficacy or safety information that could significantly affect or alter continuation of the Trial, (iii) Sponsor terminates its conduct of the entire Trial in Sponsor’s sole discretion; oror (iv) there is a violation or a suspected violation by Institution or Investigator of any Applicable Law, the Protocol or this Agreement, as determined within Sponsor’s reasonable discretion. The date of termination will be the date specified in such notice.

Immediate Termination by Sponsor. Sponsor may terminate this Agreement, terminate the conduct of the Trial under this Agreement, or terminate or suspend enrollment or randomization of Trial Participants immediately upon written notice to Provider and/or Institution and Investigator if (i) the Provider Institution or Investigator fails to meet enrollment goals of the Trial as specified in the Protocol within the timeframe, if any, specified by Sponsor or fails to enroll any patient within the first 3 months after Trial initiationinitiation by Institution, (ii) Sponsor becomes aware of any efficacy or safety information that could significantly affect or alter continuation of the Trial, (iii) Sponsor terminates its conduct of the entire Trial in Sponsor’s sole discretion; oror (iv) there is a violation or a suspected violation by Institution or Investigator of any Applicable Law, the Protocol or this Agreement, as determined within Sponsor’s reasonable discretion. The 15.4

Immediate Termination by Sponsor. Sponsor may terminate this Agreement, terminate the conduct of the Trial under this Agreement, or terminate or suspend enrollment or randomization of Trial Participants immediately upon written notice to Provider and/or Institution and Investigator if if (i) the Provider Institution or Investigator fails to meet enrollment goals of the Trial as specified in the Protocol within the timeframe, if any, specified by Sponsor or fails to enroll any patient within the first 3 months after Trial initiation, (ii) Sponsor becomes aware of any efficacy or safety information that could significantly affect or alter continuation of the Trial, (iii) Sponsor terminates its conduct of the entire Trial in Sponsor’s sole discretion; oror (iv) there is a violation or a suspected violation by Institution or Investigator of any Applicable Law, the

Immediate Termination by Sponsor. Sponsor may terminate this Agreement, terminate the conduct of the Trial under this Agreement, or terminate or suspend enrollment or randomization of Trial Participants immediately upon written notice to Provider and/or Institution and Investigator if if (i) the Provider Institution or Investigator fails to meet enrollment goals of the Trial as specified in the Protocol within the timeframetimeframe in written form, if any, specified by Sponsor or fails to enroll any patient within the first 3 months after Trial initiation, (ii) Sponsor becomes aware of any efficacy or safety information that could significantly affect or alter continuation of the Trial, (iii) Sponsor terminates its conduct of the entire Trial in Sponsor’s sole discretion; or,